Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?

Bibliography

• Theuretzbacher U, Toney JH. Nature’s clarion call of antibacterial resistance: are we listening? Curr Opin Investig Drugs 2006;7(2):158-66
   PubMed Web of Science ®Google Scholar
• Ling LL, Schneider T, Peoples AJ, et al. A new antibiotic kills pathogens without detectable resistance. Nature 2015;517(7535):455-9
   PubMed Web of Science ®Google Scholar
• Rosaschino F, Cattaneo L. Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL). Acta Biomed 2004;75(3):171-8
   PubMedGoogle Scholar
• Barken KB, Haagensen JA, Tolker-Nielsen T. Advances in nucleic acid-based diagnostics of bacterial infections. Clin Chim Acta 2007;384(1-2):1-11
   PubMed Web of Science ®Google Scholar
• Cottell JL, Saw HT, Webber MA, Piddock LJ. Functional genomics to identify the factors contributing to successful persistence and global spread of an antibiotic resistance plasmid. BMC Microbiol 2014;14:168
   PubMedGoogle Scholar
• Kim DH, Choi JY, Kim HW, et al. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands. Antimicrob Agents Chemother 2013;57(11):5239-46
   PubMed Web of Science ®Google Scholar
• Itokawa K, Komagata O, Kasai S, et al. Global spread and genetic variants of the two CYP9M10 haplotype forms associated with insecticide resistance in Culex quinquefasciatus Say. Heredity 2013;111(3):216-26
   PubMed Web of Science ®Google Scholar
• Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62(Pt 4):499-513
   PubMedGoogle Scholar
• Ndowa F, Lusti-Narasimhan M, Unemo M. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect 2012;88(5):317-18
   PubMed Web of Science ®Google Scholar
• Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 2011;6(4):407-22
   PubMed Web of Science ®Google Scholar
• Yamane K, Wachino J, Doi Y, et al. Global spread of multiple aminoglycoside resistance genes. Emerg Infect Dis 2005;11(6):951-3
   PubMed Web of Science ®Google Scholar
• NIAID. NIAID’s antibacterial resistance program: current status and future directions. NIAID 2014;1(1):13
   Google Scholar
• Hugh TB. Howard Florey, Alexander Fleming and the fairy tale of penicillin. Med J Aust 2002;177(1):2
   Google Scholar
• Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 2005;36(6):697-705
   PubMed Web of Science ®Google Scholar
• Sutcliffe JA. Improving on nature: antibiotics that target the ribosome. Curr Opin Microbiol 2005;8(5):534-42
   PubMed Web of Science ®Google Scholar
• Levy SB, McMurry LM, Burdett V, et al. Nomenclature for tetracycline resistance determinants. Antimicrob Agents Chemother 1989;33(8):1373-4
   PubMed Web of Science ®Google Scholar
• Ban N, Nissen P, Hansen J, et al. The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution. Science 2000;289(5481):905-20
   PubMed Web of Science ®Google Scholar
• Cech TR. The ribosome is a ribozyme. Science 2000;289(5481):878-9
   PubMed Web of Science ®Google Scholar
• Wannigama DL, Dwivedi R, Zahraei-Ramazani A. Prevalence and antibiotic resistance of gram-negative pathogenic bacteria species isolated from Periplaneta americana and Blattella germanica in Varanasi, India. J Arthropod-Borne Dis 2014;8(1):10-20
   Web of Science ®Google Scholar
• Aksoy MD, Cavuslu S, Tugrul HM. Investigation of Metallo Beta Lactamases and Oxacilinases in Carbapenem Resistant Acinetobacter baumannii Strains Isolated from Inpatients. Balkan Med J 2015;32(1):79-83
   PubMed Web of Science ®Google Scholar
• Pray L. Antibiotic resistance, mutation rates and MRSA. Nat Educ 2008;1(1):30
   Google Scholar
• Gustafsson I, Sjolund M, Torell E, et al. Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother 2003;52(4):645-50
   PubMed Web of Science ®Google Scholar
• Davies J. Origins and evolution of antibiotic resistance. Microbiologia 1996;12(1):9-16
   PubMedGoogle Scholar
• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010;74(3):417-33
   PubMed Web of Science ®Google Scholar
• Crespi BJ. The evolution of social behavior in microorganisms. Trends Ecol Evol 2001;16(4):178-83
   PubMed Web of Science ®Google Scholar
• Lewis K. Platforms for antibiotic discovery. Nat Rev Drug Discov 2013;12(5):371-87
   PubMed Web of Science ®Google Scholar
• Keyser P, Elofsson M, Rosell S, Wolf-Watz H. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J Intern Med 2008;264(1):17-29
   PubMed Web of Science ®Google Scholar
• Penchovsky R. Programmable and automated bead-based microfluidics for versatile DNA microarrays under isothermal conditions. Lab Chip 2013;13(12):10
   Google Scholar
• Penchovsky R, McCaskill JS. Cascadable hybridisation transfer of specific DNA between microreactor selection modules. Lect Notes Comput Sci 2002;2340:10
   Google Scholar
• Penchovsky R, Birch-Hirschfeld E, McCaskill JS. End-specific covalent photo-dependent immobilisation of synthetic DNA to paramagnetic beads. Nucleic Acids Res 2000;28(22):E98
   PubMed Web of Science ®Google Scholar
• Blount K, Puskarz I, Penchovsky R, Breaker R. Development and application of a high-throughput assay for glmS riboswitch activators. RNA Biol 2006;3(2):77-81
   PubMedGoogle Scholar
• Blount KF, Breaker RR. Riboswitches as antibacterial drug targets. Nat Biotechnol 2006;24(12):1558-64
   PubMed Web of Science ®Google Scholar
• Penchovsky R, Breaker RR. Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes. Nat Biotechnol 2005;23(11):1424-33
   PubMed Web of Science ®Google Scholar
• Penchovsky R. Computational design and biosensor applications of small molecule-sensing allosteric ribozymes. Biomacromolecules 2013;14(4):1240-50
   PubMed Web of Science ®Google Scholar
• Penchovsky R. Present and future RNA-based approaches to medical genomics. Int J Genomic Med 2013;1(2):6
   Google Scholar
• Penchovsky R. Nucleic Acids-based Nanotechnlogy: Engineering Principals and Applications. In: Bououdina M, Davim JP, editors, Handbook of research on nanoscience, nanotechnology, and advanced materials. Engineering Science Reference (An Imprint of IGI Global); 2014:414-30
   Google Scholar
• Penchovsky R. Computational design of allosteric ribozymes as molecular biosensors. Biotechnol Adv 2014;32(5):1015-27
   PubMed Web of Science ®Google Scholar
• Agresti JJ, Antipov E, Abate AR, et al. Ultrahigh-throughput screening in drop-based microfluidics for directed evolution. Proc Natl Acad Sci USA 2010;107(9):4004-9
   PubMed Web of Science ®Google Scholar
• Schonbrun E, Abate AR, Steinvurzel PE, et al. High-throughput fluorescence detection using an integrated zone-plate array. Lab Chip 2010;10(7):852-6
   PubMed Web of Science ®Google Scholar
• Manganelli G, Masullo U, Filosa S. HTS/HCS to screen molecules able to maintain embryonic stem cell self-renewal or to induce differentiation: overview of protocols. Stem Cell Rev 2014;10(6):802-19
   PubMed Web of Science ®Google Scholar
• Azegrouz H, Karemore G, Torres A, et al. Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness. J Biomol Screen 2013;18(10):1270-83
   PubMed Web of Science ®Google Scholar
• Bai H, Xue X, Hou Z, et al. Antisense antibiotics: a brief review of novel target discovery and delivery. Curr Drug Discov Technol 2010;7(2):76-85
   PubMedGoogle Scholar
• Winkler WC, Cohen-Chalamish S, Breaker RR. An mRNA structure that controls gene expression by binding FMN. Proc Natl Acad Sci USA 2002;99(25):15908-13
   PubMed Web of Science ®Google Scholar
• Lee ER, Blount KF, Breaker RR. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol 2009;6(2):187-94
   PubMed Web of Science ®Google Scholar
• Penchovsky R, Stoilova CC. Riboswitch-based antibacterial drug discovery using high-throughput screening methods. Expert Opin Drug Discov 2013;8(1):65-82
   PubMed Web of Science ®Google Scholar
• Chan JH, Lim S, Wong WS. Antisense oligonucleotides: from design to therapeutic application. Clin Exp Pharmacol Physiol 2006;33(5-6):533-40
   PubMed Web of Science ®Google Scholar
• Dryselius R, Nekhotiaeva N, Nielsen PE, Good L. Antibiotic-free bacterial strain selection using antisense peptide nucleic acid. Biotechniques 2003;35(5):1060-4
   PubMed Web of Science ®Google Scholar
• Ray A, Norden B. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J 2000;14(9):1041-60
   PubMed Web of Science ®Google Scholar
• Stock RP, Olvera A, Scarfi S, et al. Inhibition of neomycin phosphorotransferase expression in Entamoeba histolytica with antisense peptide nucleic acid (PNA) oligomers. Arch Med Res 2000;31(4 Suppl):S271-2
   Google Scholar
• Shiraishi T, Nielsen PE. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers. Artif DNA PNA XNA 2011;2(3):90-9
   PubMedGoogle Scholar
• Fillion P, Desjardins A, Sayasith K, Lagace J. Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides. Biochim Biophys Acta 2001;1515(1):44-54
   PubMed Web of Science ®Google Scholar
• Moulton HM. Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers. Methods Mol Biol 2012;867:407-14
   PubMedGoogle Scholar
• Qadir MI. Review: Phage therapy: A modern tool to control bacterial infections. Pak J Pharm Sci 2015;28(1):265-70
   PubMed Web of Science ®Google Scholar
• Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage 2011;1(2):111-14
   PubMedGoogle Scholar
• Agne M, Blank I, Emhardt AJ, et al. Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation. ACS Synth Biol 2014;3(12):986-9
   Web of Science ®Google Scholar
• Barrangou R, May AP. Unraveling the potential of CRISPR-Cas9 for gene therapy. Expert Opin Biol Ther 2014;1-4
   Google Scholar
• Gilgenkrantz H. [The revolution of the CRISPR is underway]. Med Sci 2014;30(12):1066-9
   Google Scholar
• Fairhead H. SASP gene delivery: a novel antibacterial approach. Drug News Perspect 2009;22(4):197-203
   PubMed Web of Science ®Google Scholar
• Gaspar D, Veiga AS, Castanho MA. From antimicrobial to anticancer peptides. A review. Front Microbiol 2013;4:294
   PubMed Web of Science ®Google Scholar
• Aoki W, Ueda M. Characterization of antimicrobial peptides toward the development of novel antibiotics. Pharmaceuticals 2013;6(8):1055-81
   Google Scholar
• Bahar AA, Ren D. Antimicrobial peptides. Pharmaceuticals 2013;6(12):1543-75
   Google Scholar
• Seo MD, Won HS, Kim JH, et al. Antimicrobial peptides for therapeutic applications: a review. Molecules 2012;17(10):12276-86
   PubMed Web of Science ®Google Scholar
• Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 2009;15(21):2377-92
   PubMed Web of Science ®Google Scholar
• Potashman MH, Formella DN, Hamed K, Mohr JF. Comment on: Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials. J Antimicrob Chemother 2014;69(12):3181-89
   PubMed Web of Science ®Google Scholar
• McElvania TeKippe E, Thomas BS, Ewald GA, et al. Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum... a cautionary tale. Eur J Clin Microbiol Infect Dis 2014;33(12):2199-205
   PubMed Web of Science ®Google Scholar
• Kai-Larsen Y, Gudmundsson GH, Agerberth B. A review of the innate immune defence of the human foetus and newborn, with the emphasis on antimicrobial peptides. Acta Paediatr 2014;103(10):1000-8
   PubMed Web of Science ®Google Scholar
• Dean SN, Bishop BM, van Hoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 2011;11:114
   PubMed Web of Science ®Google Scholar
• Lee DK, Park JE, Kim MJ, et al. Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients. Clin Res Hepatol Gastroenterol 2015;39(2):237-44
   PubMed Web of Science ®Google Scholar
• Kelly CP. Fecal microbiota transplantation–an old therapy comes of age. N Engl J Med 2013;368(5):474-5
   PubMed Web of Science ®Google Scholar
• Marianelli C, Cifani N, Pasquali P. Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp. enterica serovar typhimurium 1344 in a common medium under different environmental conditions. Res Microbiol 2010;161(8):673-80
   PubMed Web of Science ®Google Scholar
• Kizerwetter-Swida M, Binek M. Selection of potentially probiotic Lactobacillus strains towards their inhibitory activity against poultry enteropathogenic bacteria. Pol J Microbiol 2005;54(4):287-94
   PubMedGoogle Scholar
• Kirst HA. Developing new antibacterials through natural product research. Expert Opin Drug Discov 2013;8(5):14
   Google Scholar
• Foster KR. Social behaviour in microorganisms. Soc Behav 2010;1(1):39
   Google Scholar